Miliary EGFR mutated non-small cell lung cancer

被引:0
|
作者
Nguyen, Mike M. [1 ]
Moore, Melissa M. [1 ]
机构
[1] St Vincents Hosp Melbourne, Melbourne, Vic, Australia
关键词
D O I
10.5694/mja2.50901
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:118 / 118
页数:1
相关论文
共 50 条
  • [1] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] MILIARY METASTASES ARE ASSOCIATED WITH EGFR MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hsu, Fred
    Toriumi, Ted
    De Caluwe, Alex
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S57 - S57
  • [3] Treatment strategy of EGFR-mutated non-small cell lung cancer
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    Kuroda, Koji
    [J]. JOURNAL OF THORACIC DISEASE, 2022, 14 (03) : 602 - 606
  • [4] Emerging drugs for EGFR-mutated non-small cell lung cancer
    Sukrithan, Vineeth
    Deng, Lei
    Barbar, Alexander
    Cheng, Haiying
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (01) : 5 - 16
  • [5] How to Treat EGFR-Mutated Non-Small Cell Lung Cancer
    Belani, Neel
    Liang, Katherine
    Fradley, Michael
    Judd, Julia
    Borghaei, Hossein
    [J]. JACC: CARDIOONCOLOGY, 2023, 5 (04): : 542 - 545
  • [6] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [7] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [8] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [9] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Shepherd, Annemarie F.
    Preeshagul, Isabel R.
    Shaverdian, Narek
    Wu, Abraham J.
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Rimner, Andreas
    Simone, Charles B., II
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)